Clinical Trials Browser

Phase 2 × Prostatic Neoplasms × Coffee × Clear all

NCT05478239 2026-02-05

ArtemiCoffee in Patients With Rising PSA

Phase 2 Active not recruiting

Prostatic Neoplasms